{"id":"W2001366190","doi":"10.1007/s10549-007-9502-2","title":"Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"University of Pennsylvania","keywords":"Gefitinib; Breast cancer; In vivo; Medicine; Cancer research; PI3K/AKT/mTOR pathway; Epidermal growth factor receptor; MCF-7; EGFR inhibitors; Cancer; Protein kinase B; Pharmacology; Oncology; Internal medicine; Biology; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009439814,0.0002158432,0.0004612851,0.0004714057,0.0003498138,0.0003391897,0.0001412168,0.0003207738,0.002418166],"category_scores_gemma":[0.00009726323,0.000184555,0.0001688268,0.0002752119,0.0002224089,0.0002403038,0.0001699732,0.0004803588,0.0003310324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003121182,"about_ca_system_score_gemma":0.0001793658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00145111,"about_ca_topic_score_gemma":0.001477517,"domain_scores_codex":[0.9998312,0.00001886983,0.000012258,0.00002584548,0.00005502919,0.00005674861],"domain_scores_gemma":[0.9999028,0.00001069521,0.00002668237,0.000006804585,0.00001469989,0.00003826045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004761849,0.00003138792,0.00109458,0.00002977255,0.00001536259,0.0001027485,0.00003018509,0.00003920498,0.9966789,0.00007250819,0.0001119943,0.0013172],"study_design_scores_gemma":[0.00002135333,0.0004421805,0.07335099,0.000004347593,0.00005099819,0.001377354,0.0001489092,0.000620432,0.9211414,0.00007825187,0.002753698,0.00001011904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934008,0.002244308,0.001043849,0.0001810108,0.00003785909,0.00001038234,0.0009660583,0.00009363952,0.002022087],"genre_scores_gemma":[0.9939618,0.0007191827,0.001207363,0.00008113421,0.00002068044,0.00003872201,0.001154504,0.0000269526,0.002789619],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002418166,"threshold_uncertainty_score":0.008089542,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05867916153529029,"score_gpt":0.3396418979712968,"score_spread":0.2809627364360066,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}